A non-ionic phenothiazine-derived type I photosensitizer

Area of Science:

• Organic Chemistry
• Photochemistry
• Cancer Biology

Background:

• Non-ionic phenothiazine (PTZ) derivatives are common in optoelectronics and fluorescent probes.
• Their utility as Type I photosensitizers (PSs) for photodynamic therapy (PDT) is underexplored.

Purpose of the Study:

• To investigate novel PTZ-based donor-acceptor dyes as Type I PSs.
• To evaluate their potential for photodynamic cancer therapy, particularly under hypoxic conditions.

Main Methods:

• Synthesis and characterization of PTZ-1 and PTZ-2 dyes.
• Photodynamic studies measuring reactive oxygen species (ROS) generation (hydroxyl radicals and superoxide).
• In vitro phototoxicity assays on 4T1 cancer cells, including studies under hypoxia.
• Confocal microscopy for cellular uptake and localization.
• Apoptosis assays (Annexin V-FITC/PI staining, Western blot).

Main Results:

• PTZ-1 and PTZ-2 efficiently generate hydroxyl radicals and superoxide under irradiation, confirming Type I behavior.
• PTZ-1 exhibits strong phototoxicity against 4T1 cancer cells (IC50 = 0.63 μM) with minimal dark toxicity.
• PTZ-1 demonstrates potent efficacy under hypoxic conditions, indicating low oxygen dependence.
• PTZ-1 selectively accumulates in lipid droplets and induces apoptosis via ROS generation, not ferroptosis.

Conclusions:

• Non-ionic PTZ derivatives can function as effective Type I photosensitizers.
• PTZ-1 is a promising candidate for lipid-droplet-targeted photodynamic cancer therapy, especially in hypoxic tumors.
• The Type I mechanism offers an alternative to traditional Type II PDT, which relies heavily on oxygen levels.